Viswanathan Natarajan Selected Research

phosphatidylbutanol

5/2009

Phospholipase D-mediated activation of IQGAP1 through Rac1 regulates hyperoxia-induced p47phox translocation and reactive oxygen species generation in lung endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Viswanathan Natarajan Research Topics

Disease

28	Lung Injury 01/2022 - 04/2003
24	Inflammation (Inflammations) 01/2021 - 08/2002
20	Hyperoxia 01/2022 - 01/2003
17	Pneumonia (Pneumonitis) 03/2022 - 04/2009
16	Acute Lung Injury 01/2022 - 09/2005
13	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2021 - 08/2012
13	Fibrosis (Cirrhosis) 08/2020 - 01/2013
11	Infections 03/2021 - 07/2003
11	Neoplasms (Cancer) 12/2019 - 02/2003
9	Asthma (Bronchial Asthma) 09/2021 - 04/2007
8	Bronchopulmonary Dysplasia 01/2022 - 10/2013
8	Sepsis (Septicemia) 09/2021 - 04/2009
7	Hypoxia (Hypoxemia) 09/2021 - 12/2010
7	Lung Diseases (Lung Disease) 03/2020 - 11/2006
6	Lung Neoplasms (Lung Cancer) 09/2021 - 01/2008
6	Idiopathic Pulmonary Fibrosis 03/2020 - 04/2013
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 12/2003
3	Chronic Obstructive Pulmonary Disease (COPD) 03/2022 - 09/2009
3	Ventilator-Induced Lung Injury 01/2022 - 12/2015
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2016
3	Pulmonary Edema 01/2022 - 12/2003
3	Pathologic Processes 01/2020 - 05/2009
3	Pulmonary Arterial Hypertension 01/2018 - 10/2009
3	Prostatic Neoplasms (Prostate Cancer) 06/2013 - 12/2010
3	Breast Neoplasms (Breast Cancer) 12/2010 - 10/2004
2	Retinoblastoma (Glioblastoma, Retinal) 08/2022 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 03/2022 - 01/2022
2	Airway Remodeling 01/2022 - 01/2020
2	COVID-19 01/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
2	Pulmonary Hypertension 09/2021 - 11/2014
2	Respiratory Hypersensitivity 01/2020 - 11/2008
2	Necrosis 01/2019 - 01/2015
2	Vascular Remodeling 01/2018 - 12/2017
2	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 09/2009
2	Respiratory Insufficiency (Respiratory Failure) 01/2018 - 04/2012

Drug/Important Bio-Agent (IBA)

24	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 09/2021 - 08/2002
20	Proteins (Proteins, Gene)FDA Link 08/2022 - 04/2003
19	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2003
15	SphingolipidsIBA 01/2022 - 08/2002
13	sphingosine kinaseIBA 01/2022 - 08/2010
13	lysophosphatidic acidIBA 09/2021 - 03/2009
12	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 01/2003
12	LipidsIBA 06/2020 - 05/2005
11	SphingosineIBA 01/2022 - 04/2009
11	CytokinesIBA 01/2022 - 09/2005
11	Small Interfering RNA (siRNA)IBA 01/2016 - 08/2007
10	EnzymesIBA 09/2021 - 05/2005
10	Bleomycin (Blenoxane)FDA LinkGeneric 08/2020 - 04/2013
9	Phosphotransferases (Kinase)IBA 01/2022 - 01/2003
8	Tyrosine (L-Tyrosine)FDA Link 05/2015 - 04/2003
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2005
7	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2016 - 01/2003
6	Superoxides (Superoxide)IBA 11/2017 - 01/2003
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2006
5	CortactinIBA 01/2022 - 08/2007
5	Phosphates (Orthophosphate)IBA 09/2021 - 05/2009
5	Phospholipids (Phosphatides)FDA LinkGeneric 09/2021 - 05/2006
5	AllergensIBA 01/2020 - 02/2006
5	Sphingosine-1-Phosphate ReceptorsIBA 12/2019 - 10/2010
5	1-dodecylpyridoxal (PLD)IBA 01/2019 - 04/2003
5	CeramidesIBA 01/2018 - 05/2005
5	LyasesIBA 01/2017 - 10/2013
5	Lysophosphatidic Acid ReceptorsIBA 12/2013 - 11/2009
4	LipopolysaccharidesIBA 01/2022 - 05/2006
4	Extracellular Matrix ProteinsIBA 06/2020 - 12/2013
4	sphingosine 1-phosphate lyase (aldolase)IBA 01/2018 - 08/2011
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016 - 06/2013
4	PaxillinIBA 12/2015 - 01/2008
3	SmokeIBA 03/2022 - 01/2021
3	PF-543IBA 01/2022 - 01/2020
3	Nicotinamide PhosphoribosyltransferaseIBA 01/2022 - 11/2005
3	Biological ProductsIBA 01/2022 - 05/2011
3	Mitochondrial DNA (mtDNA)IBA 08/2020 - 01/2019
3	Peptides (Polypeptides)IBA 01/2020 - 08/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 05/2005
3	Phospholipase DIBA 01/2019 - 04/2003
3	Histones (Histone)IBA 01/2019 - 01/2012
3	NADP (NADPH)IBA 12/2017 - 01/2003
3	NADPH Oxidase 4IBA 11/2017 - 06/2011
3	Organophosphonates (Phosphonates)IBA 01/2016 - 07/2013
3	Particulate MatterIBA 04/2012 - 11/2008
2	Cardiolipins (Cardiolipin)IBA 03/2022 - 06/2014
2	NF-kappa B (NF-kB)IBA 01/2022 - 01/2005
2	LigandsIBA 01/2022 - 01/2021
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2016
2	Oxygen (Dioxygen)IBA 09/2021 - 01/2013
2	AsbestosIBA 08/2020 - 01/2020
2	LysophospholipidsIBA 06/2020 - 01/2020
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2020 - 01/2012
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2009
2	Oxidants (Oxidizing Agents)IBA 01/2020 - 12/2005
2	Phosphatidic Acids (Phosphatidic Acid)IBA 01/2019 - 02/2015
2	indium-bleomycinIBA 01/2019 - 04/2013
2	Protein Kinase CIBA 01/2019 - 03/2011
2	AldehydesIBA 01/2017 - 11/2006

Therapy/Procedure

12	Therapeutics 01/2022 - 05/2005
7	Mechanical Ventilators (Ventilator) 01/2022 - 04/2009
3	Artificial Respiration (Mechanical Ventilation) 01/2018 - 07/2013